Novem Group Medpace Holdings, Inc. Transaction History
Novem Group
- $686 Billion
- Q4 2024
A detailed history of Novem Group transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Novem Group holds 2,161 shares of MEDP stock, worth $743,297. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,161Holding current value
$743,297% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding MEDP
# of Institutions
623Shares Held
25.7MCall Options Held
74.3KPut Options Held
79.1K-
Black Rock Inc. New York, NY2.58MShares$887 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$884 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA1.08MShares$373 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT937KShares$322 Million1.56% of portfolio
-
State Street Corp Boston, MA780KShares$268 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.7B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...